(Companies Covered: Sanofi, GlaxoSmithKline, Novartis, Johnson & Johnson, Roche, Eli Lilly, AstraZeneca, Teva Pharmaceutical, Regeneron Pharmaceuticals, Bausch Health.)
The global interleukin inhibitors market is expected to decline from $18.22 billion in 2019 to $17.93 billion in 2020 at a compound annual growth rate of -1.58%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $26.88 billion in 2023 at a compound annual growth rate of 14.44%.
Read More On The Global Interleukin Inhibitors Market Report At –
The interleukin inhibitors market consists of the sales of interleukin inhibitors such as interleukin -1, interleukin -5, interleukin -6, interleukin -17, interleukin 23, by companies that manufacture them. These interleukin inhibitors are used for the treatment of autoimmune and inflammatory disorders such as psoriasis, psoriatic arthritis, rheumatoid arthritis, asthma, and inflammatory bowel disease
Global Interleukin Inhibitors Market Segmentation –
1) By Type: IL-17, IL-23, IL-1, IL-5, IL-6, Others.
2) By Application: Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Asthma, Inflammatory Bowel Disease, Others.
3) By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.
Global Interleukin Inhibitors Market Driver –
An increase in the number of investigational drugs for inflammatory diseases such as psoriasis, arthritis, and inflammatory bowel disease will drive the interleukin inhibitors market. Inhibitors of interleukin decrease the actions of the inflammatory cytokines, stimulate innate immune responses preventing damage to the host, and maintain normal tissue homeostasis.
Request For A Sample Of The Global Interleukin Inhibitors Market Report At –
Few Points From The Global Interleukin Inhibitors Market TOC
1. Executive Summary
2. Interleukin Inhibitors Market Characteristics
3. Interleukin Inhibitors Market Size And Growth
3.1. Global Interleukin Inhibitors Historic Market, 2015 – 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Interleukin Inhibitors Forecast Market, 2019 – 2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Interleukin Inhibitors Market Segmentation
4.1. Global Interleukin Inhibitors Market, Segmentation By Type, Historic and Forecast, 2015-2019,
2023F, 2025F, 2030F, $ Billion
4.2. Global Interleukin Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015
2019, 2023F, 2025F, 2030F, $ Billion
4.3. Global Interleukin Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5. Interleukin Inhibitors Market Regional And Country Analysis
5.1. Global Interleukin Inhibitors Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Interleukin Inhibitors Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.
Company Name: The Business Research Company
Contact Person: Oliver Guirdham
Email: Send Email
Phone: +44 20 7193 0708
State: Greater London
Country: United Kingdom